Pharmaceutical Sciences Master |
Kernfächer I |
Nummer | Titel | Typ | ECTS | Umfang | Dozierende |
---|
535-0030-00L | Therapeutic Proteins | O | 3 KP | 3G | C. Halin Winter,
D. Neri |
535-0041-00L | Pharmacology and Toxicology III | O | 2 KP | 2G | M. Detmar,
U. Quitterer |
535-0050-00L | Pharmacoepidemiology and Drug Safety | O | 3 KP | 2G | S. Russmann |
535-0546-00L | Patente | O | 1 KP | 1V | A. Koepf,
P. Pliska |
511-0000-00L | Drug Discovery and Development | O | 2 KP | 2G | U. Thibaut,
J. Hall |
511-0007-00L | Scientific Writing and Presenting Number of participants limited to 24. | O | 2 KP | 2G | G. Schneider,
J. Dolenc,
J. A. Hiss,
J.‑C. Leroux,
O. Renn,
J. Schnabl |
|
Wahlfächer I |
Nummer | Titel | Typ | ECTS | Umfang | Dozierende |
---|
535-0011-00L | Drug Seminar Die Belegung dieser Lerneinheit ist nur für Studierende möglich, die im Master Pharmazie oder im Master Pharmaceutical Sciences eingeschrieben sind. | W | 5 KP | 9S | C. Halin Winter,
K.‑H. Altmann,
S. M. Ametamey,
M. Detmar,
B. A. Gander,
J. Hall,
S.‑D. Krämer,
J.‑C. Leroux,
C. Müller,
D. Neri,
V. I. Otto,
U. Quitterer,
R. Schibli,
G. Schneider,
C. Steuer,
H. U. Zeilhofer |
511-1001-00L | Biopharmacy (Crash Course) Obligatory course if assigned by the Admission committee. | E- | 2 KP | 1S | S.‑D. Krämer |
511-1002-00L | Pharmaceutical Analytics and Pharmacopeia (Crash Course) Obligatory course if assigned by the Admission committee. | E- | 2 KP | 1S | C. Steuer |
511-1003-00L | Gene Technology (Crash Course) Obligatory course if assigned by the Admission committee. | E- | 1 KP | 1S | J. Scheuermann |
535-0423-00L | Drug Delivery and Drug Targeting | W | 2 KP | 1.5V | J.‑C. Leroux,
A. Spyrogianni Roveri |
535-0250-00L | Biotransformation of Drugs and Xenobiotics | W | 1 KP | 1V | S.‑D. Krämer |
535-0015-00L | Geschichte der Pharmazie | W | 1 KP | 1V | M. Fankhauser |
535-0344-00L | Von Ethnopharmazie zu molekularer Pharmakognosie | W | 1 KP | 1V | B. Frei Haller,
J. Gertsch |
535-0310-00L | Glycobiology in Drug Development | W | 1 KP | 1V | V. I. Otto |
535-0300-00L | Molecular Mechanisms of Drug Actions and Targets Maximale Teilnehmerzahl: 24 | W | 2 KP | 1V | V. I. Otto,
J. Scheuermann |
535-0021-00L | Vitamine in der Vorsorge und Therapie | W | 1 KP | 1V | C. Müller |
535-0360-00L | Rationale Phytotherapie an ausgewählten Beispielen | W | 1 KP | 1V | J. Drewe,
K. Berger Büter |
535-0137-00L | Clinical Chemistry II | W | 1 KP | 1V | M. Hersberger |
535-0022-00L | Computer-Assisted Drug Design | W | 1 KP | 1V | G. Schneider |